334 - Mini-Oral Abstracts Session
Islet, xenotransplant and cellular therapies

Tuesday September 13, 2022 | 16:25 to 17:25
Room: C5
Track: N/A

Description

For attending this session, you can claim 1 EACCME credits

Presentations

Dr. Mateusz Ogledzinski, United States
Modified approach for improved islet allotransplantation into pre-vascularized cell pouch device - preliminary results of the phase I/II clinical trial at University of Chicago

Dr. Norifumi Kanai, Japan
A Gelatin Hydrogel Nonwoven Fabric Improves Outcomes of Subcutaneous Islet Transplantation

Dr. Esma S. Yolcu, United States
Presentation of FasL protein by PEG microgels within graft site leads to survival of pancreatic islets in nonhuman primates without the need for chronic immunosuppression

Rebecca Craig-Schapiro, United States
Adaptable endothelium enables subcutaneous transplantation of islets to treat diabetes

Dr. Erin M Duggan, United States
Evidence for xenogeneic hematopoiesis after peripheral blood stem cell transplantation from a novel transgenic pig with knock-in hIL-3 receptor

Prof. Elmar Jaeckel, Canada
Porcine SLA-specific CAR Treg enable xenotransplantation in the absence of immunosuppression

Wayne Hawthorne, Australia
Xenotransplantation of genetically modified neonatal pig islets cures diabetes in baboons

Mr. Winston Jaramillo, Ecuador
Custom bone massive allograft for lower limb salvage surgery, the impact of imaging and 3D printing. Experience of the tissue bank of the Hospital Luis Vernaza. 2016-2021

Mrs. Perrine Burdeyron, France
Development and evaluation of a cell therapy for ex vivo porcine kidney graft conditioning using exosomes derived from porcine Urine Progenitor Cells



© 2024 TTS 2022